More and more women being diagnosed with ADHD, study finds
Click here for updates on this story
Stay updated with breaking news from Epic Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Click here for updates on this story
GLP-1 drugs such as Wegovy and Ozempic, used for controlling diabetes and weight loss, may help lower the likelihood of depression and anxiety, new research indicates.
Add depression to the growing list of chronic diseases that obesity medicines might alleviate. Signs of improved mental health are showing up in the health records of people who take
For the millions of people who take Ozempic and Wegovy, weight loss is the best-known outcome — but a new study suggests the medications could also help squash depression. Investigators from Epic Research, a health analytics firm based in Verona, Wisconsin, found that patients with diabetes who were prescribed glucagon-like peptide-1 receptor agonist (GLP-1) medications
For those who take Ozempic or Wegovy for weight loss or diabetes, a new study suggests the GLP-1 medications could also help reduce depression and anxiety.